彭浡, 王建荣. 基于晶体工程设计的药物-药物复合物研究进展J. 药学学报, 2020,55(10): 2358-2367. doi: 10.16438/j.0513-4870.2020-0603
引用本文: 彭浡, 王建荣. 基于晶体工程设计的药物-药物复合物研究进展J. 药学学报, 2020,55(10): 2358-2367. doi: 10.16438/j.0513-4870.2020-0603
PENG Bo, WANG Jian-rong. Advances in drug-drug complexes based on the crystal engineering design J. Acta Pharmaceutica Sinica, 2020,55(10): 2358-2367. doi: 10.16438/j.0513-4870.2020-0603
Citation: PENG Bo, WANG Jian-rong. Advances in drug-drug complexes based on the crystal engineering design J. Acta Pharmaceutica Sinica, 2020,55(10): 2358-2367. doi: 10.16438/j.0513-4870.2020-0603

基于晶体工程设计的药物-药物复合物研究进展

Advances in drug-drug complexes based on the crystal engineering design

  • 摘要: 基于晶体工程设计的药物-药物共晶/盐等药物-药物复合物,不仅对具有水溶性差、生物利用度低、不稳定等特点的活性药物成分(APIs)的溶解度、溶出速率、稳定性等物理化学性质改善具有重要意义,还在实现联合用药中发挥重要作用。本文概述了近年来基于晶体工程设计的多种药物-药物共晶/盐等的设计、合成、表征、物理化学和药理学性质变化、多晶型、研发管线等,为开发新型固态组合药物提供理论支持。

     

    Abstract: Drug-drug complexes play important roles in improving the physicochemical properties of drugs including the solubility, dissolution rate and stability of the active pharmaceutical ingredients (APIs). In this paper, the design, synthesis, characterization, changes in physicochemical and pharmacologic properties, structural polymorphisms and the research and development pipelines of a variety of drug-drug cocrystals/salts synthesized based on the crystal engineering design are reviewed. This may provide theoretical support for the development of the new solid-state combinational drugs.

     

/

返回文章
返回